Perioperative treatment of a patient with abdominal compartment syndrome due to neuroblastoma and hepatomegaly

Akihiro Yanagisawa, Masaru Tobe, Hiroshi Hinohara, Fumio Kunimoto, Tomonori Takazawa, Shigeru Saito

Research output: Contribution to journalArticlepeer-review

Abstract

A male infant developed abdominal compartment syndrome (ACS) due to stage-4S neuroblastoma and hepatic enlargement. Because of tumor lysis syndrome by chemotherapy and radiationtherapy, his condition deteriorated and he underwent emergent abdominal counterincision surgical operation in the intensive care unit. General anesthesia was maintained with O2 (100%), midazolam (0.25-0.3 mg·kg-1·hr-1), fentanyl, and rocuronium infusion. By removal of the ACS, the breathing improved. At the end of the operation, we inserted GamCath catheter from his internal jugular vein for CHDF performed after the operation. We used midazolam, fentanyl and rocuronium for sedation. Subsequently, 8 days later, his general condition markedly improved, and we could evade performing CHDF.

Original languageEnglish
Pages (from-to)184-187
Number of pages4
JournalJapanese Journal of Anesthesiology
Volume63
Issue number2
StatePublished - 2014

Keywords

  • Abdominal compartment syndrome
  • Continuous hemodiafiltration (CHDF)
  • Neuroblastoma

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Fingerprint

Dive into the research topics of 'Perioperative treatment of a patient with abdominal compartment syndrome due to neuroblastoma and hepatomegaly'. Together they form a unique fingerprint.

Cite this